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A 16-year-old boy was referred with multiple episodes of
nephrolithiasis since the age of 8 years. Plain abdominal film
at first presentation revealed a small staghorn calculus
obstructing the ureter and multiple stones within the right
renal pelvis (Figure 1). The past medical, surgical and family
history was unremarkable and the boy was not receiving any
medication. He was referred to a hospital specialized in
pediatric urology where extended nephropyelolithotomy with
lower pole resection was performed. After the procedure,
right-sided split renal function improved from 16 to 36%.
Over the next 7 years, episodes of nephrolithiasis were
initially confined to the right kidney for which he received
in total 12 extracorporeal lithotripsy sessions and 2 open
nephrolithotomies. In December 2004, his right kidney was
found to be atrophic with 1.6% split function. At this time,
stone formation had also been noted on the left side, and
again was treated with extracorporeal lithotripsy. Before
removal of the right kidney in 2006, a normal urinary
calcium excretion was noted and the nephrectomy specimen
was reported as ‘an atrophic kidney with chronic interstitial
nephritis’. We were subsequently able to review the pathology
slides (Figure 2).
What do you see in the pathological specimen?
What is your clinical diagnosis?
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Figure 1 | Plain abdominal film at time of first
presentation (2000): A small staghorn calculus
obstructing the ureter and multiple stones
within the renal pelvis.
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Figure 2 | Histology slides from nephrectomized kidney.
(a) Cortical, periodic acid–Schiff-stained section of nephrectomized
right kidney (original magnification  40). (b) Enlarged area
from panel (a) (original magnification  400); periodic
acid–Schiff.
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The Diagnosis | Primary hyperoxaluria type II (PH II)
Review of renal pathology specimens (Figure 2a) revealed
chronic interstitial fibrosis, severe tubular atrophy/loss,
and focal lymphoplasmacytic infiltrates. On high-power
(Figure 2b) examination, tubular cross-sections revealed
fragmented epithelial wall and obstructed lumina due to
calcium oxalate deposits. The birefringent nature of the
crystals can be easily seen in polarized light (Figure 3), which
is suggestive of calcium oxalate, a remarkable find-
ing however not reported by the consulted pathologist
(Figure 2a and b). Hyperoxaluria of 41 mmol/1.73 m2/day
(normal o0.5) and L-glyceric aciduria of 662 mmol/mol
creatinine (normal o32) were noted.
Metabolic disorders are the most common cause of
urolithiasis in childhood. A history of frequent calculi should
always raise suspicion of an underlying disease. Despite
recurrent stones needing frequent interventions, proper evalua-
tion had not been carried out in this case until it was late.
Two rare genetic forms of primary hyperoxaluria (PH)
are currently known: PH type I is caused by absence of
or low catalytic activity of liver-specific alanine-glyoxylate
aminotransferase. PH type II is less common and is caused
by defective glyoxylate reductase/hydroxypyruvate reduc-
tase (GRHPR). Clinical hallmarks in both are recurrent
urolithiasis and/or progressive nephrocalcinosis; however, PH
I has a more severe phenotype, with end-stage renal failure
being the regular outcome.1,2 A discriminator is the increased
excretion of urinary glycolate in most patients with PH I, or
L-glycerate in PH II.3 A significant number of patients are
diagnosed late or even only in end-stage renal failure.4 Liver
biopsy is still considered the gold standard for diagnosis, but
mutational analysis has become increasingly reliable.5 In our
case diagnosis was established by a homozygous mutation
(103delG) of the GRHPR gene.
Although unlikely in this case, PH has to be differentiated
from the (more common) secondary causes. Therefore
intestinal (hyper) absorption can be quantified by the
13C2-oxalate absorption test (which in our case was 6.5%—
well within normal limits).
Hydration and urine alkalization are still the backbone of
conservative therapy. Pyridoxine treatment can be effective in
PH I. Extensive stone removal procedures to the uncompli-
cated calculi should be avoided. Combined liver–kidney
(PH I) or isolated kidney transplantation (PH II) are the
treatments of choice in end-stage renal failure.
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Figure 3 | Birefringent calcium oxalate aggregates
by polarized light, some with a typical envelope
structure.
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